1. Takahashi M. Kawasaki syndrome (Mucocutaneous lymph
node syndrome). In: Allen HD,
Gutgesell HP, Clark EB, Driscoll
DJ (eds). Congenital Heart
Disease in Infants, Children and
Adolescents. 5th ed. Philadelphia:
Lippincott Williams & Wilkins,
1995: 1390-1399.
2. Rowley AH, Shulman ST.
Kawasaki Syndrome. Pediatr Clin
North Am 1999; 46: 313-330.
3. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific
desquamation of the fingers and
toes in children. Clinical observation of 50 patients. Jpn J Allergy
1967; 16: 178-222.
4. Laupland KB, Davies HD. Epidemiology, etiology, and management of Kawasaki disease: state of
the art. Pediatr Cardiol 1999; 20:
177-183.
5. Rowley AH. Incomplete (atypical) Kawasaki disease. Pediatr
Infect Dis J 2002; 21: 563-566.
6. Barone SR, Pontrelli LR, Krilov
LR. The differentiation of classic
Kawasaki disease, atypical
Kawasaki disease, and acute adenoviral infection. Arch Pediatr
Adolesc Med 2000; 154: 453-456.
7. Boven K, De Graeff-Meeder ER,
Spliet W, Kuis W. Atypical
Kawasaki disease: an often missed
diagnosis. Eur J Pediatr 1992;
151: 577-580.
8. Avner JR, Shaw KT, Chin AJ.
Atipical presentation of Kawasaki
disease with early development of
giant coronary artery aneurysms.
J Pediatr 1989; 114: 605-606.
9. Arjunan K, Daniels SR, Meyer
RA, Schwartz DC, Barron H,
Kaplan S. Coronary artery caliber
in normal children and patients
with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. J
Am Coll Cardiol 1986; 8: 1119-
1124.
10. Iemura M, Ishii M, Sugimura T,
Akagi T, Kato H. Long term consequences of regressed coronary
aneursyms after Kawasaki disease:
vascular wall morphology and
function. Heart 2000; 83: 307-
311.
11. Brogan PA, Bose A, Burgner D,
et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for
future research. Arch Dis Child
2002; 86: 286-290.
12. Saulsbury FT. Comparison of
high-dose and low-dose aspirin
plus intravenous immunoglobulin in the treatment of Kawasaki
syndrome. Clin Pediatr 2002; 41:
597-601.
13. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki
disease. Pediatrics 1978; 61: 100-
107.
14. LeJemtel TH, Demopoulos LA,
Bijou R. Progressive left ventricular dysfunction: mechanical
remodeling versus continuous
cell loss. Heart Failure 1994; 10:
28-40.
15. Kitamura S, Kawashima Y, Fujita
T, Mori T, Oyama C. Aortocoronary bypass grafting in a child
with coronary artery obstruction
due to mucocutaneous lymphnode syndrome: report of a case.
Circulation 1976; 53: 1035-1040.
16. Kitamura S, Kawachi K, Oyama
C, et al. Severe Kawasaki heart
disease treated with an internal
mammary artery graft in pediatric
patients. A first successful report.
J Thorac Cardiovasc Surg 1985;
89: 860-866.
17. Kitamura S, Kameda Y, Seki T, et
al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. Thorac Cardiovasc
Surg 1994; 107: 663-673.
18. Yamauchi H, Ochi M, Hinokiyama K, et al. Optimal time of
surgical treatment for coronary
artery disease. J Nippon Med Sch
2004; 71: 279-286
Thank you for copying data from http://www.arastirmax.com
